Prestige BioPharma Limited (KRX:950210)
South Korea
· Delayed Price · Currency is KRW
9,620.00
-390.00 (-3.90%)
At close: Mar 9, 2026
Prestige BioPharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is July - June.
Millions KRW. Fiscal year is Jul - Jun.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 6, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Market Capitalization | 115,024 | 176,683 | 103,966 | 113,582 | 137,620 | 396,635 | |
| Market Cap Growth | -36.20% | 69.94% | -8.47% | -17.47% | -65.30% | - | |
| Enterprise Value | 204,060 | 210,197 | 44,042 | -6,736 | -150,494 | -63,944 | |
| Last Close Price | 9570.00 | 14700.00 | 8650.00 | 9450.00 | 11450.00 | 33000.00 | |
| PE Ratio | 42.08 | 7.92 | - | 6.47 | - | - | |
| Forward PE | - | 12.01 | 12.01 | 12.01 | 12.01 | - | |
| PS Ratio | 6.05 | 12.33 | 150.88 | 701.81 | - | - | |
| PB Ratio | 0.24 | 0.35 | 0.20 | 0.21 | 0.32 | 0.69 | |
| P/TBV Ratio | 0.32 | 0.48 | 0.26 | 0.28 | 0.32 | 0.69 | |
| EV/Sales Ratio | 10.73 | 14.67 | 63.92 | - | - | - | |
| Debt / Equity Ratio | 0.18 | 0.28 | 0.17 | 0.21 | 0.01 | 0.01 | |
| Debt / EBITDA Ratio | - | - | - | 9.11 | - | - | |
| Net Debt / Equity Ratio | 0.01 | -0.06 | -0.26 | -0.34 | -0.69 | -0.78 | |
| Net Debt / EBITDA Ratio | -0.07 | 0.66 | 2.89 | -14.65 | 2.52 | 27.01 | |
| Net Debt / FCF Ratio | -0.05 | 0.32 | 1.95 | 1.71 | 2.92 | 27.54 | |
| Asset Turnover | 0.03 | 0.02 | 0.00 | 0 | - | - | |
| Inventory Turnover | 0.98 | 1.18 | 0.89 | 0.01 | - | - | |
| Quick Ratio | 0.74 | 1.05 | 1.53 | 2.24 | 7.26 | 32.70 | |
| Current Ratio | 1.03 | 1.27 | 1.72 | 2.31 | 7.46 | 32.74 | |
| Return on Equity (ROE) | -0.86% | 0.81% | -10.38% | -0.59% | -42.08% | -2.07% | |
| Return on Assets (ROA) | -6.42% | -5.71% | -5.35% | 0.10% | -13.89% | -3.01% | |
| Return on Capital Employed (ROCE) | -13.30% | -11.50% | -11.00% | 0.20% | -26.80% | -3.10% | |
| Earnings Yield | 11.89% | 12.62% | -31.66% | 15.47% | -153.65% | -1.86% | |
| FCF Yield | -57.97% | -52.57% | -65.49% | -95.65% | -74.36% | -4.13% | |
| Buyback Yield / Dilution | -0.25% | -0.44% | 0.22% | - | -16.46% | -20.98% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.